Latest niche market research study on “Global Chronic Obstructive Pulmonary Disease (COPD) Market 2017 Industry Trend and Forecast 2021” published at Orbisresearch.com
Chronic Obstructive Pulmonary Disease (COPD) Market Insights, Epidemiology and Market Forecast-2023 Report provides an overview of the disease and global market size of the Chronic Obstructive Pulmonary Disease (COPD) for the 7MM (United States, EU5 (France, Germany, Italy, Spain and UK) and Japan. It also includes global historical and forecasted epidemiological data for the Prevalence cases of COPD from 2013-2023.
Attractive Discount Details on Purchase of This Report:
Get Flat 15% on Single User License, Flat 25% on Site License & Flat 30% on Enterprise Licence
Offer Last 30th June
Get a PDF Sample of Report at: http://www.orbisresearch.com/contacts/request-sample/209376 .
Chronic Obstructive Pulmonary Disease (COPD) is a chronic respiratory disease which progresses slowly and cause difficulty in emptying the air out of the lungs. It is the leading cause of mortality and morbidity worldwide. It is characterized by airflow limitation caused by excess production of mucus which is followed by airway hyperactivity. It causes thickening of airways and destruction of tissue essential for exchanging air in lungs which decreases the flow of air in and out of lungs. This ultimately results in shortness of breath. Chronic Obstructive Pulmonary Disease (COPD) is most commonly of two types Chronic bronchitis and Emphysema. World Health Organization estimates Chronic Obstructive Pulmonary Disease (COPD) to be the fourth commonest cause of death by 2030 after ischemic heart disease, cerebrovascular disease, and HIV/AIDS. According to, the worldwide COPD market is estimated to be USD 27.89 Billion by 2023 at a CAGR of 10.54%.
- Scope of the Report
- Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
- Marketed information including available prescription drugs, its patent and exclusivity details.
- The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5 and Japan from 2013-2023.
- It also provides Market size of COPD for United States, EU5 and Japan from 2013 and forecasted Market size to 2023.
Purchase a copy of Chronic Obstructive Pulmonary Disease (COPD)-Market Insights, Epidemiology and Market Forecast-2023 @ http://www.orbisresearch.com/contact/purchase/209376 .
List Of Tables:
Table 1: Prevalent Population of COPD in United States (2013-2023)
Table 2: Prevalent Population of COPD in United Kingdom (2013-2023)
Table 3: Prevalent Population of COPD in France (2013-2023)
Table 4: Prevalent Population of COPD in Italy (2013-2023)
Table 5: Prevalent Population of COPD in Germany (2013-2023)
Table 6: Prevalent Population of COPD in Spain (2013-2023)
Table 7: Prevalent Population of COPD in Japan by Sub-Types (2013-2023)
Table 8: List of Marketed Drugs
Table 9: Approval, Patent Expiry & Annual Cost of Marketed Drugs
Table 10: Emerging Therapies for Chronic Obstructive Pulmonary Disease (COPD),2016
For any enquires before buying, connect with us @ email@example.com
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
For More Press Releases, visit: http://orbisnewsrelease.com/